Related references
Note: Only part of the references are listed.Controlling drug nanoparticle formation by rapid precipitation
Suzanne M. D'Addio et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Polymeric multilayer capsules delivering biotherapeutics
Stefaan De Koker et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Novel antiangiogenic agents in dermatology
Ricardo L. Berrios et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Endothelial Nox4 NADPH Oxidase Enhances Vasodilatation and Reduces Blood Pressure In Vivo
Robin Ray et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells
Patricia Sancho et al.
BIOCHEMICAL PHARMACOLOGY (2011)
NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action
Vincent Jaquet et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
Radhamani Kannaiyan et al.
CANCER LETTERS (2011)
Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2
Gabor Csanyi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR
Ana M. Briones et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2011)
Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis through a PPARα Mediated Mechanism
Sarah Garrido-Urbani et al.
PLOS ONE (2011)
A Novel and Specific NADPH Oxidase-1 (Nox1) Small-Molecule Inhibitor Blocks the Formation of Functional Invadopodia in Human Colon Cancer Cells
Davide Gianni et al.
ACS CHEMICAL BIOLOGY (2010)
Redox Stimulation of Cardiomyogenesis Versus Inhibition of Vasculogenesis Upon Treatment of Mouse Embryonic Stem Cells with Thalidomide
Nada Milosevic et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Peptide-based inhibitors of the phagocyte NADPH oxidase
Jamel El-Benna et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
S. Wind et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Oxidative Stress and Endothelial Dysfunction in Aortas of Aged Spontaneously Hypertensive Rats by NOX1/2 Is Reversed by NADPH Oxidase Inhibition
Sven Wind et al.
HYPERTENSION (2010)
NADPH Oxidases Regulate CD44 and Hyaluronic Acid Expression in Thrombin-treated Vascular Smooth Muscle Cells and in Atherosclerosis
Aleksandr E. Vendrov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Nox4 B-loop Creates an Interface between the Transmembrane and Dehydrogenase Domains
Heather M. Jackson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
Benoit Laleu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Small-Molecule Inhibitors of NADPH Oxidase 4
Gabor Borbely et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis
Min Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy
M. Sedeek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Reactive oxygen species are involved in regulating α1-adrenoceptor-activated vascular smooth muscle contraction
Ming-Ho Tsai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Small-Molecule NOX Inhibitors: ROS-Generating NADPH Oxidases as Therapeutic Targets
Vincent Jaquet et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation
Feng Wu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species
Sabine Lange et al.
CARDIOVASCULAR RESEARCH (2009)
Celastrol binds to ERK and inhibits FcεRI signaling to exert an anti-allergic effect
Youngmi Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
NOX and inflammation in the vascular adventitia
Gabor Csanyi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Nox proteins in signal transduction
David I. Brown et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Classical Inhibitors of NOX NAD(P) H Oxidases Are Not Specific
Elisabetta Aldieri et al.
CURRENT DRUG METABOLISM (2008)
Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species
Hideki Sumimoto
FEBS JOURNAL (2008)
Mutational Analysis Reveals Distinct Features of the Nox4-p22phox Complex
Katharina Von Loehneysen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
Tao Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
NADPH oxidases in the vasculature: Molecular features, roles in disease and pharmacological inhibition
Stavros Selemidis et al.
PHARMACOLOGY & THERAPEUTICS (2008)
NOX enzymes as novel targets for drug development
J. David Lambeth et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases
Ralf P. Brandes et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2008)
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
J. David Lambeth
FREE RADICAL BIOLOGY AND MEDICINE (2007)
NADPH oxidase inhibitors: New anti hypertensive agents?
Holly C. Williams et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology
Karen Bedard et al.
PHYSIOLOGICAL REVIEWS (2007)
Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
Anita M. Brinker et al.
PHYTOCHEMISTRY (2007)
Mycophenolate acid inhibits endothelial NAD(P)H oxidase activity and superoxide formation by a Rac1-dependent mechanism
Florian Kroetz et al.
HYPERTENSION (2007)
NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells
Nicole Duerrschmidt et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice
Betsy N. Perry et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Pro-atherogenic effect of interleukin-4 in endothelial cells: Modulation of oxidative stress, nitric oxide and monocyte chernoattractant protein-1 expression
L. Walch et al.
ATHEROSCLEROSIS (2006)
Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation
Henrik ten Freyhaus et al.
CARDIOVASCULAR RESEARCH (2006)
Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells
C Stielow et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery
M Weaver et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Targeting reactive oxygen species in hypertension
ME Cifuentes et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases
KD Martyn et al.
CELLULAR SIGNALLING (2006)
Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy
M Al-Shabrawey et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery
HM Dourron et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation
R Fürst et al.
CIRCULATION RESEARCH (2005)
gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension
O Jung et al.
CIRCULATION (2004)
Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy
JH Liu et al.
CIRCULATION RESEARCH (2004)
Vascular NAD(P)H oxidases:: specific features, expression, and regulation
B Lassègue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy
JH Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery
GM Jacobson et al.
CIRCULATION RESEARCH (2003)
Two novel proteins activate superoxide generation by the NADPH oxidase NOX1
B Bánfi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Rac-dependent monocyte chemoattractant protein-1 production is induced by nutrient deprivation
NHM Lopes et al.
CIRCULATION RESEARCH (2002)
NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment
F Krötz et al.
BLOOD (2002)
Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries - Regulation by angiotensin II
RM Touyz et al.
CIRCULATION RESEARCH (2002)
Mapping of functional domains in the p22phox subunit of flavocytochrome b559 participating in the assembly of the NADPH oxidase complex by peptide walking
I Dahan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
S17834, a new inhibitor of cell adhesion and atherosclerosis that targets NADPH oxidase
AJ Cayatte et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease
AC Allison et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2001)
Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O2- and systolic blood pressure in mice
FE Rey et al.
CIRCULATION RESEARCH (2001)
Novel gp91phox homologues in vascular smooth muscle cells -: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways
B Lassègue et al.
CIRCULATION RESEARCH (2001)
Share Paper
